Please assess the completion status of the following clinical trial:

Trial Title: An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria:~1. Men 18 years of age and older.~2. Able to speak, read and understand English.~3. Willing to participate in the study and voluntarily sign an informed consent document.~Exclusion criteria:~1. Subject or anyone in their household is currently employed by a marketing or marketing research company, and advertising agency or public relations firm, a pharmacy or pharmaceutical company, a manufacturer of medicines, a managed care or health insurance company as a healthcare professional or healthcare practice.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- tamsulosin hydrochloride (Type: EXPERIMENTAL): patients will take drug for 8 weeks in this exploratory study

Based on this trial design, predict the completion outcome and termination type (if applicable).